Perampanel 12 mg film-coated tablets clinical trials

Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 12 mg film-coated tablets versus reference product Fycompa 12 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions.

This study compares two versions of the same medicine, Perampanel, to make sure they work the same way in the body. It's a small study in healthy adults, helping ensure new generic medicines are just as effective as their original counterparts.